These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 9376343)

  • 41. The structural and functional essentiality of the N-terminal alpha-helix in the phospholipase A2 of the Taiwan banded krait.
    Chang LS; Chang CC; Wu PF
    Biochem Mol Biol Int; 1997 May; 41(6):1247-53. PubMed ID: 9161720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Conformational changes associated with activation of bee venom phospholipase A2.
    Ahmed T; Kelly SM; Lawrence AJ; Mezna M; Price NC
    J Biochem; 1996 Dec; 120(6):1224-31. PubMed ID: 9010774
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evidence for association of an ATP-stimulatable Ca(2+)-independent phospholipase A2 from pancreatic islets and HIT insulinoma cells with a phosphofructokinase-like protein.
    Ramanadham S; Wolf MJ; Ma Z; Li B; Wang J; Gross RW; Turk J
    Biochemistry; 1996 Apr; 35(17):5464-71. PubMed ID: 8611537
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of human recombinant type II phospholipase A2 and prostaglandin F2 alpha release by microtubule depolymerizing agents.
    Munns MJ; King RG; Rice GE
    Clin Exp Pharmacol Physiol; 1999 Mar; 26(3):230-5. PubMed ID: 10081619
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Human myocardial cytosolic Ca(2+)-independent phospholipase A2 is modulated by ATP. Concordant ATP-induced alterations in enzyme kinetics and mechanism-based inhibition.
    Hazen SL; Gross RW
    Biochem J; 1991 Dec; 280 ( Pt 3)(Pt 3):581-7. PubMed ID: 1764021
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Origins of delays in monolayer kinetics: phospholipase A2 paradigm.
    Cajal Y; Berg OG; Jain MK
    Biochemistry; 2004 Jul; 43(28):9256-64. PubMed ID: 15248783
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant human synovial fluid phospholipase A2 and N-terminal variant: kinetic parameters and response to inhibitors.
    Märki F; Hanulak V
    J Biochem; 1993 Jun; 113(6):734-7. PubMed ID: 8370672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils. A potential role of heparan sulfate binding in PLA2 internalization and degradation.
    Kim KP; Rafter JD; Bittova L; Han SK; Snitko Y; Munoz NM; Leff AR; Cho W
    J Biol Chem; 2001 Apr; 276(14):11126-34. PubMed ID: 11118430
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A continuous fluorescence assay for phospholipase A2 with nontagged lipid.
    Huang C; Zhou L; Liu Y; Lai L
    Anal Biochem; 2006 Apr; 351(1):11-7. PubMed ID: 16510113
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel transglutaminase-mediated post-translational modification of phospholipase A2 dramatically increases its catalytic activity.
    Cordella-Miele E; Miele L; Mukherjee AB
    J Biol Chem; 1990 Oct; 265(28):17180-8. PubMed ID: 1976627
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The role of propeptide in the refolding of human group IB phospholipase A2.
    Cheng HQ; Xu GJ
    Acta Biochim Biophys Sin (Shanghai); 2004 Sep; 36(9):583-8. PubMed ID: 15346194
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Biochemical, Kinetic and Biological Properties of Group V Phospholipase A2 from Dromedary.
    Alonazi M; Karray A; Jallouli R; Ben Bacha A
    Molecules; 2022 May; 27(11):. PubMed ID: 35684381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Highly Enantioselective Semisynthesis of (+)/(-)-Gossypol Schiff Base Derivatives from Ground Plant Material.
    Sidi Boune MV; Elemine B; Aliyenne A; Hadou A; Daïch A; Othman M; Lawson AM
    J Nat Prod; 2019 Jul; 82(7):1779-1790. PubMed ID: 31294981
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Preparation and functional analysis of gossypols having two carbohydrate appendages with enaminooxy linkages.
    Amano Y; Nakamura M; Shiraishi S; Chigira N; Shiozawa N; Hagio M; Yano T; Hasegawa T
    Carbohydr Res; 2018 Mar; 458-459():67-76. PubMed ID: 29466762
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Interfacial enzymology: the secreted phospholipase A(2)-paradigm.
    Berg OG; Gelb MH; Tsai MD; Jain MK
    Chem Rev; 2001 Sep; 101(9):2613-54. PubMed ID: 11749391
    [No Abstract]   [Full Text] [Related]  

  • 56. Reactions of proteins with gossypol.
    LYMAN CM; BALIGA BP; SLAY MW
    Arch Biochem Biophys; 1959 Oct; 84():486-97. PubMed ID: 14419129
    [No Abstract]   [Full Text] [Related]  

  • 57. Assay of phospholipases A(2) and their inhibitors by kinetic analysis in the scooting mode.
    Jain MK; Yu BZ; Gelb MH; Berg OG
    Mediators Inflamm; 1992; 1(2):85-100. PubMed ID: 18475447
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Specific Regulation of Enzymatic Activity by Interface Pulses.
    Hanisch DT; Schneider MF
    Langmuir; 2024 Feb; ():. PubMed ID: 38330005
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Optimizing drug discovery for snakebite envenoming via a high-throughput phospholipase A2 screening platform.
    Albulescu LO; Westhorpe A; Clare RH; Woodley CM; James N; Kool J; Berry NG; O'Neill PM; Casewell NR
    Front Pharmacol; 2023; 14():1331224. PubMed ID: 38273832
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Gossypol increases expression of the pro-apoptotic BH3-only protein NOXA through a novel mechanism involving phospholipase A2, cytoplasmic calcium, and endoplasmic reticulum stress.
    Soderquist RS; Danilov AV; Eastman A
    J Biol Chem; 2014 Jun; 289(23):16190-9. PubMed ID: 24778183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.